高级检索
当前位置: 首页 > 详情页

Polyphenols of Chinese skullcap roots: from chemical profiles to anticancer effects.

文献详情

资源类型:
Pubmed体系:

收录情况: ◇ EI

机构: [1]School of Pharmacy, Nanjing University of Chinese Medicine Nanjing City Jiangsu Province 210023 P. R. China [2]School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong Pokfulam Hong Kong SAR P. R. China [3]First Affiliated Hospital of Guangzhou Medical University Guangzhou City Guangdong Province 510120 P. R. China
出处:

摘要:
Great efforts have been made to identify the principle bioactive constituents of Chinese herbs and to unravel the molecular mechanisms behind their anticancer effects. Scutellaria baicalensis (Huangqin or Chinese skullcap) is a widely consumed herbal medicine and has been historically used in anticancer therapy in China and other countries. Chinese skullcap generates many active chemicals in the root and is abundant in polyphenols, which act as its anti-cancer ingredients. It contains around 53 polyphenols in total: 50 flavonoids and 3 stilbenes. The polyphenols have similar chemical structures since they are derived from similar biochemical synthetic pathways. According to the literature, as the active chemicals of the skullcap root, 18 polyphenols exhibit evident anticancer activities. They can be developed not only as novel candidates and precursors in anticancer drug screening, but also as important tools and agents in cancer pharmacology. We comprehensively elaborated the anticancer pharmacological properties of crude polyphenolic extracts and 12 other single compounds excluding the six well-known polyphenols, i.e., baicalein, baicalin, wogonin, wogonoside, chrysin and verbascoside. In this review, we also discussed the possible mechanisms of the anticancer effect of several skullcap polyphenols. Overall, this paper provides a unique path to understand the anticancer properties of Chinese skullcap as well as guidance to find novel anticancer drugs from a natural polyphenolic reservoir.This journal is © The Royal Society of Chemistry.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 3 区 化学
小类 | 3 区 化学综合
最新[2025]版:
大类 | 3 区 化学
小类 | 3 区 化学:综合
第一作者:
第一作者机构: [1]School of Pharmacy, Nanjing University of Chinese Medicine Nanjing City Jiangsu Province 210023 P. R. China [2]School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong Pokfulam Hong Kong SAR P. R. China
共同第一作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2020 今日访问量:0 总访问量:646 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号